NCT01887002View on ClinicalTrials.gov

Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

PHASE2TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2015

Conditions
Irritable Bowel Syndrome (IBS)
Interventions
DRUG

ONO-2952

ONO-2952 Active tablets, every day for 2 weeks

DRUG

Placebo comparator

ONO-2952 Matching Placebo every day for 2 weeks

Trial Locations (4)

27599

Chapel Hill Clinical Site, Chapel Hill

63110

St. Louis Clinical Site, St Louis

73160

Oklahoma City Clinical Site, Oklahoma City

02215

Boston Clinical Site, Boston

Sponsors

Lead Sponsor

Ono Pharma USA Inc
All Listed Sponsors
lead

Ono Pharma USA Inc

INDUSTRY